KP Biomedical Engineering - Issue #28

-ZEISS Vision Care Launches DuraVision® Gold UV AR, The New Gold Standard in Lens Coatings HEBRON, Ky.--(BUSINESS WIRE)

--ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, announced the launch of ZEISS DuraVision Gold UV AR, the latest high-clarity, anti-reflective lens coating in the ZEISS DuraVision portfolio. With its striking gold residual reflectance, the new coating radiates luxury, elegance, and sophistication.

-CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production CLICHY, France--(BUSINESS WIRE)

--CorWave, a French company developing and manufacturing innovative cardiac assist devices, announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations. Dawn Sadlowski-Buisserez brings extensive experience in implantable medical devices to support CorWave's production scale-up. Her expertise is a major asset for CorWave's industrial development and its transition to the clinical phase.

-Paragonix to Showcase Extensive Organ Transplant Research at the 45th Annual Meeting of the International Society of Heart and Lung Transplantation WALTHAM, Mass.--(BUSINESS WIRE)

--Paragonix Technologies, Inc., a pioneer in organ transplant products and services, is honored to announce the forthcoming release of new clinical data supporting the use of FDA-cleared and CE marked controlled hypothermic preservation devices and transplant services.

-$5+ Billion Needle Free Drug Delivery Devices Market Industry Trends, Competitive Landscape and Forecasts to 2035 - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)

--The "Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route of Administration, Actuation Mechanism, Product Usability, Application Area, Type of Load, Microneedle, Material Used, Intervention and Geography" report has been added to ResearchAndMarkets.com's offering.

-Needles Market Industry Trends, Global Forecasts to 2035 and Key Player Analysis including BD, Medtronic, Braun, Novo Nordisk, Roche and more - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)

--The "Needles Market Industry Trends and Global Forecasts to 2035, Distribution by Type of Needle based on Design, Type of Needle based on Purpose, Mode of Delivery, Type of Material, End Users, Geographical Regions and Leading Players" report has been added to ResearchAndMarkets.com's offering. The global needles market size is estimated to grow from USD 8.1 billion in the current year to USD 14.7 billion by 2035, at a CAGR of 6.1% during the forecast period, till 2035.

-CONMED Corporation to Announce First Quarter 2025 Financial Results on April 30, 2025 LARGO, Fla.--(BUSINESS WIRE)

--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2025 after the market close on Wednesday, April 30, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

-KARL STORZ Introduces the Slimline C-MAC S Single-Use Video Laryngoscope EL SEGUNDO, Calif.--(BUSINESS WIRE)

--KARL STORZ announces the worldwide launch of the Slimline C-MAC® S single-use video laryngoscope for airway management. Built to the same high-quality standards as all KARL STORZ products, the Slimline C-MAC S blade delivers clear visibility for a confident intubation, even in the most challenging cases.

-Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025 ACTON, Mass.--(BUSINESS WIRE)

--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced plans to release its financial results for the first quarter of 2025 on May 8, 2025, after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

-Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries EDEN PRAIRIE, Minn.--(BUSINESS WIRE)

--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced the commercial release of the Pounce™ XL Thrombectomy System, the latest in a suite of Pounce Thrombectomy systems that provide rapid endovascular removal of acute or chronic clot from peripheral arteries.

-Anaconda Biomed Enrolls First U.S. Patient in the ATHENA Clinical Trial Evaluating ANA Funnel Catheter for Ischemic Stroke Treatment BARCELONA, Spain & MARIN, Calif.--(BUSINESS WIRE)

--Anaconda Biomed, S.L., a medical technology company developing next generation neurothrombectomy devices, announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical trial by Shahram Majidi, MD, Associate Professor of Neurosurgery, Neurology, and Radiology at Icahn School of Medicine at Mount Sinai, New York.

-Wolters Kluwer and Laerdal Medical Enhance VR Simulation for Nursing Education With Conversational AI WALTHAM, Mass.--(BUSINESS WIRE)

--Bringing together two of the most exciting technologies driving the education and healthcare industries forward, Wolters Kluwer Health announced the addition of conversational artificial intelligence (AI) to vrClinicals for Nursing. Since its launch together with Laerdal Medical in 2023, vrClinicals for Nursing has been a leading virtual reality (VR) solution in bridging the gap between classroom theory and clinical practice.

-Vanderbilt Health Performs First Successful Kidney Transplant Using New Organ Preservation Technology NASHVILLE, Tenn.--(BUSINESS WIRE)

--Paragonix Technologies, Inc., a leader in organ preservation technology, and Vanderbilt Health, one of the oldest and largest kidney transplant programs in the country, are proud to announce the successful transplantation of a donor kidney using the Paragonix KidneyVault™ Renal Perfusion System. The FDA-cleared portable hypothermic perfusion technology is designed to preserve and transport donor kidneys.

-U.S. FDA Grants Paige Breakthrough Device Designation for AI Application that Detects Cancer Across Different Anatomic Sites NEW YORK--(BUSINESS WIRE)

--Paige, a leader in next-generation AI technology, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to Paige PanCancer Detect*, an AI-assisted diagnostic application intended to assist pathologists in the detection of foci that are suspicious for cancer across a wide range of tissue from multiple organs.

-Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits MÄNNEDORF, Switzerland--(BUSINESS WIRE)

--Tecan Group (SIX Swiss Exchange: TECN) announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two in vitro diagnostic (IVD) products for specialty diagnostics and disease monitoring, and two research-use-only (RUO) kits.

-restor3d Secures $38 Million in Growth Capital to Drive Expansion and Innovation in Personalized Orthopedic Solutions DURHAM, N.C.--(BUSINESS WIRE)

--restor3d, a leader in 3D printed, personalized orthopedic implant care, announced the successful completion of capital raising efforts totaling $38 million. These funding rounds included participation from both existing and new private investors, including Summers Value Partners. The investments will fuel the company’s continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026.

-Viz.ai Wins 2025 Edison Award™ for Machine Learning Innovation for the Third Consecutive Year SAN FRANCISCO--(BUSINESS WIRE)

--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced that it has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. Viz HCM, the company’s AI software solution designed to detect and triage patients with signs of hypertrophic cardiomyopathy (HCM), was recognized in the Health Medical & Biotech category and Cardiovascular Health Diagnostics and Monitoring subcategory.

-University of Arizona Study Finds Openwater’s Open-LIFU 2.0 Device Achieves Significant Depression Symptom Reduction After Less Than Two Hours Total Treatment Time SAN FRANCISCO--(BUSINESS WIRE)

--Openwater, an open-source medical technology company delivering portable, hospital-grade diagnostic and therapeutic devices, announced compelling results from a University of Arizona study published in Frontiers in Psychiatry. The study, “Transcranial Focused Ultrasound Targeting the Default Mode Network for the Treatment of Depression” utilized Openwater’s Open-LIFU 2.0 device to deliver targeted, low-intensity transcranial focused ultrasound pulses.

-Pulse oximeter accuracy varies across skin pigment groups

--The differences, or bias, between estimates of blood oxygen saturation levels as measured with pulse oximeters compared to the gold-standard method of measuring oxygen saturation in arterial blood varied significantly between patients with darkly pigmented skin compared to lighter skin pigment, according to research presented at the American College of Cardiology's Annual Scientific Session.

-AI-based imaging performs equally well as ultrasound in guiding heart procedures

--Patients with narrowing of at least 50% in three major coronary arteries did equally well when treated with a minimally invasive stent placement guided either by ultrasound-based imaging or by a novel, artificial-intelligence-powered (AI), non-invasive imaging technique derived from angiography, researchers reported at the American College of Cardiology's Annual Scientific Session (ACC.25).

-Embolic protection device does not reduce stroke rate in TAVR procedure

--A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the rate of stroke, according to a randomized trial presented at the American College of Cardiology's Annual Scientific Session.

-AI model achieves high accuracy in detecting odontogenic sinusitis in dental X-rays

--The Ateneo Laboratory for Intelligent Visual Environments (ALIVE) and international researchers have developed a deep learning model that aims to revolutionize dentistry, with the capability to identify tooth and sinus structures in dental X-rays with an accuracy of 98.2%.

-New AI voice screening method improves detection of anxiety and depression

--Scientists at the National Center for Supercomputing Applications and the University of Illinois College of Medicine Peoria (UICOMP) were authors of a research paper published in the Journal of Acoustical Society of America Express Letters that demonstrates improved, automated screening methods for anxiety and major depressive disorders.

-Speech neuroprosthesis unlocks near-real-time communication for patients with paralysis

--Marking a breakthrough in the field of brain-computer interfaces (BCIs), a team of researchers from UC Berkeley and UC San Francisco has unlocked a way to restore naturalistic speech for people with severe paralysis.

-New tool helps predict CAR T therapy outcomes for lymphoma patients

--Researchers with City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, with its National Medical Center in Los Angeles ranked among the nation's top 5 cancer centers by U.S. News & World Report, and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response to chimeric antigen receptor (CAR) T cell therapy before starting the treatment, according to study results published today in Nature Medicine.

-AI-driven research aims to improve IVF success rates

--The number of successful pregnancies through IVF treatment currently stands at 30 to 50 per cent globally. By analyzing the environmental conditions in the clinics' laboratories using AI, researchers at Malmö University believe they can improve the chances of a successful outcome.

-ICRAFT platform identifies new targets for cancer immunotherapy

--Professor Zeng Zexian's team from the Center for Quantitative Biology at the Peking University Academy for Advanced Interdisciplinary Studies, in collaboration with the Peking University-Tsinghua University Joint Center for Life Sciences, has developed ICRAFT, an innovative computational platform for identifying cancer immunotherapy targets.

-New AI system enhances nurse-driven patient monitoring and saves lives

--An AI tool that analyzes nurses' data and notes detected when patients in the hospital were deteriorating nearly two days earlier than traditional methods and reduced the risk of death by over 35%, found a year-long clinical trial of more than 60,000 patients led by researchers at Columbia University.

-Machine learning models predict dementia risk among American Indian/Alaska Native adults

--Machine learning algorithms utilizing electronic health records can effectively predict two-year dementia risk among American Indian/Alaska Native adults aged 65 years and older, according to a University of California, Irvine-led study.

-Mount Sinai launches AI center to revolutionize small molecule drug discovery

--The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

-Northwestern scientists develop rapid HIV test for point-of-care diagnosis

--A team of Northwestern University scientists spanning disciplines have developed new technology that could lead to the creation of a rapid point-of-care test for HIV infection competitive with traditional lab-based HIV testing in a fraction of the time and without the need for a stressful wait while results are processed or confirmed in a clinical laboratory.

-New state-of-the-art cancer treatment center opens in Newport Beach

--USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC – Newport Beach Radiation Oncology and Imaging, a state-of-the-art radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach.

-$500,000 grant to enhance digital healthcare for Indigenous communities

--Aboriginal and Torres Strait Islanders living with chronic disease in rural areas will benefit from improved healthcare access thanks to a $500,000 grant.

-Cedars-Sinai study reveals distinct roles for AI and physicians in virtual care

--Do physicians or artificial intelligence (AI) offer better treatment recommendations for patients examined through a virtual urgent care setting? A new Cedars-Sinai study shows physicians and AI models have distinct strengths.

-Unique sound stimulation technology can relieve symptoms of motion sickness

--A research group led by Takumi Kagawa and Masashi Kato at Nagoya University Graduate School of Medicine has discovered that using "a unique sound stimulation technology"-a device that stimulates the inner ear with a specific wavelength of sound-reduces motion sickness.